logo
Select company
Select metric
$ -38.89MNet Income Common Stock
VS
Market
22
Sector
44
Industry
56
History
76
$ 9.65Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Net Income Common Stock Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Net Inc. Cmn. Historical data
DateNet Income Common Stock
6/30/2025$ -38.89M
3/31/2025$ -42.52M
12/31/2024$ -77.42M
9/30/2024$ -249.04M
6/30/2024$ -233.86M
3/31/2024$ -254.87M
12/31/2023$ -219.71M
9/30/2023$ -36.16M
6/30/2023$ -35.05M
3/31/2023$ -15.06M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Net Inc. Cmn. stands at $ -68.32M.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Net Inc. Cmn. has been $ -70.07M.
  • The median Net Inc. Cmn. for CARTESIAN THERAPEUTICS INC during this period was $ -43.86M
  • CARTESIAN THERAPEUTICS INC reached its highest Net Inc. Cmn. over the past 5 years at $ 41.73M.
  • The lowest Net Inc. Cmn. recorded by CARTESIAN THERAPEUTICS INC in the same timeframe $ -254.87M

CARTESIAN THERAPEUTICS INC's Net Inc. Cmn. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. Cmn. Benchmarks
CompanyNet Inc. Cmn.
HUMA : HUMACYTE INC $ -58.66MNWBO : NORTHWEST BIOTHERAPEUTICS INC $ -83.55MMREO : MEREO BIOPHARMA GROUP PLC $ -49.55MINBX : INHIBRX BIOSCIENCES INC $ -163.69MCRDF : CARDIFF ONCOLOGY INC $ -51.04MBTAI : BIOXCEL THERAPEUTICS INC $ -50.95MCATX : PERSPECTIVE THERAPEUTICS INC $ -94.95MADVM : ADVERUM BIOTECHNOLOGIES INC $ -183.87MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.56MLSTA : LISATA THERAPEUTICS INC $ -18.92M

Similar metrics to Net Inc. Cmn.:

Definition of Net Income Common Stock

[Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].

RNAC - Net Income Common Stock, Last 5 years

$ -254.87M

Minimum

Mar 31, 2024

$ 41.73M

Maximum

Sep 30, 2022

$ -70.07M

Average

$ -43.86M

Median

Net Inc. Cmn. Benchmark Analysis

 The chart above depicts the distribution of Net Inc. Cmn. for companies in the Total Stock Market. The average Net Inc. Cmn. of the companies is $ 9.04M with a standard deviation of $ 113.34M.
The following table provides additional summary stats:
Net Inc. Cmn. in the Market:
filtered constituents3.36K
min$ -354.46M
max$ 366.08M
average$ 9.04M
median$ -2.46M
std$ 113.34M